Involvement of both the classical and alternate pathways of complement in an ex vivo model of xenograft rejection

Transplantation

Volumn 63, Issue 7, 1997, Pages 1021-1025

  Romanella, Margarita ^a   Aminian, Atousa ^a   Adam, William R ^b   Pearse, Martin J ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT FACTOR D;

ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; GRAFT REJECTION; HEART PERFUSION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; XENOGRAFT;

ANIMALS; CARDIAC OUTPUT; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; GRAFT REJECTION; HEART RATE; HUMANS; MICE; MYOCARDIUM; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030980075     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704150-00020     Document Type: Article

References (23)

1. Auchincloss H. Xenogeneic transplantation: a review. Transplantation 1988; 46: 1.
2. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
3. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
4. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
5. Zhow XJ, Niesen N, Pawlowski I, et al. Prolongation of survival of discordant kidney xenografts by C6 deficiency. Transplantation 1990; 50: 896.
6. Brauer RB, Baldwin WM, Pruitt SK, Sanfilippo F. Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18. Transplant Proc 1994; 26: 1251.
7. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyper-acute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
8. Platt JL, Vercellotti GM, Lindman B, Oegema TR Jr, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171: 1336.
9. Forty J, Hasan R, Cary N, White DJG, Wallwork J. Hyperacute rejection of rabbit hearts by human blood is mediated by the alternative pathway of complement. Transplant Proc 1992; 24: 488.
10. Johnston PS, Wang M-W, Lim SML, Wright LJ, White DJG. Discordant xenograft rejection in an antibody-free model. Transplantation 1992; 54: 573.
11. Miyagawa S, Hirose H, Shirakura R, et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
12. Weill BJ, Regimbeau JM, Calmus Y, Chereau C, Houssin D. The alternative complement pathway in hyperacute xenograft rejection. Xeno 1994; 2: 92.
13. Termignon JL, Calmus Y, Chereau C, Kahan A, Houssin D, Weill B. In vitro analysis of complement activation in xenogeneic hyperacute rejection. Transplant Proc 1992; 24: 443.
14. Gambiez L, Salame E, Chereau C, et al. The role of natural IgM in the hyperacute rejection of discordant heart xenografts. Transplantation 1992; 54: 577.
15. Zhao Z, Termignon JL, Cardoso J, et al. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. Transplantation 1994; 57: 245.
16. Makowka L, Cramer DV, Hoffman A, Sher L, Podesta L. Pig liver xenografts as a temporary bridge for human allografting. Xeno 1993; 1: 27.
17. Harrison RA, Lachman PJ. Handbook of experimental immunology and immunochemistry. Oxford: Blackwell Scientific Publications, 1986.
18. Servais G, Walmagh J, Duchateau J. Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50). J Immunol Methods 1991; 140: 93.
19. Collins T, Palmer HJ, Whitley MZ, Neish AS, Williams AJ. A common theme in endothelial activation: insights from the structural analysis of the genes for E-selection and VCAM-1. Trends Cardiovasc Med 1993; 3: 92.
20. Pamagiototoulos S, Daly M. Effector acidosis and alkalosis on post-ischemic Ca gain in isolated rat heart. Am J Physiol 1990; 258: H281.
21. Schaapherder AF, Gooszen HG, Tebulte MT, Daha MR. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation 1995; 60: 287.
22. van Denderen BJW, Pearse MJ, Katerelos M, et al. Expression of functional decay accelerating factor (CD55) in transgenic mice protects against complement-mediated attack. Transplantation 1996; 61: 582.
23. Tearle RG, Tange MJ, Zannettino ZL, et al. The α-1,3-galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation 1996; 61: 13.